Pleiotropic Benefits with Glucagon-like Peptide-1 Receptor Agonists: A Clinical Review
In the past few years, newer classes of drugs for the treatment of type 2 diabetes mellitus have been discovered and delivered with significant glucose-lowering effect and weight reduction. Among these are glucagon-like peptide-1 receptor agonists (GLP 1 RAs), a class with the most promising results...
Збережено в:
| Автори: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wolters Kluwer Medknow Publications
2023-01-01
|
| Серія: | International Journal of Diabetes and Technology |
| Предмети: | |
| Онлайн доступ: | https://journals.lww.com/10.4103/ijdt.ijdt_19_23 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|